2X-121
(PARPi) 2X-1002
Phase 2 small_molecule active
Quick answer
2X-121 for Advanced Ovarian Cancer is a Phase 2 program (small_molecule) at Allarity Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allarity Therapeutics
- Indication
- Advanced Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active